SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-066819
Filing Date
2023-11-29
Accepted
2023-11-29 17:05:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 2023-11xx-prosupp_pfw.htm 424B5 1012288
2 GRAPHIC img20356850_0.jpg GRAPHIC 10797
3 GRAPHIC img20356850_1.jpg GRAPHIC 10838
4 GRAPHIC img20356850_2.jpg GRAPHIC 10797
  Complete submission text file 0000950170-23-066819.txt   1058340
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260010 | Film No.: 231453144
SIC: 2834 Pharmaceutical Preparations